These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38188548)

  • 1. Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis.
    Zhou W; Fan M; Li X; Yu F; Zhou E; Han X
    World J Emerg Med; 2024; 15(1):35-40. PubMed ID: 38188548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
    Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
    Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
    BioData Min; 2020; 13():17. PubMed ID: 33082858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Molecular Mechanism by which Kaempferol Attenuates Sepsis-related Acute Respiratory Distress Syndrome Based on Network Pharmacology and Experimental Verification.
    Ding W; Huang C; Chen J; Zhang W; Wang M; Ji X; Nie S; Sun Z
    Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38321908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
    Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments.
    Zeng L; Lin Z; Kang P; Zhang M; Tang H; Li M; Xu K; Liu Y; Jiang Z; Huo S
    Evid Based Complement Alternat Med; 2022; 2022():2322417. PubMed ID: 36193152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
    Xing Y; Hua YR; Shang J; Ge WH; Liao J
    Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology to explore the anti-inflammatory mechanism of Xuebijing in the treatment of sepsis.
    Zhou W; Lai X; Wang X; Yao X; Wang W; Li S
    Phytomedicine; 2021 May; 85():153543. PubMed ID: 33799226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the mechanism of Shexiang Tongxin dropping pill in the treatment of microvascular angina through network pharmacology and molecular docking.
    Chang C; Ren Y; Su Q
    Ann Transl Med; 2022 Sep; 10(18):983. PubMed ID: 36267750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Targets and Mechanisms of
    Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
    Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Huaiqihuang in treatment of diabetic kidney disease based on network pharmacology, molecular docking and in vitro experiment.
    Wang J; Ma G; Zhang P; Ma C; Shao J; Wang L; Ma C
    Medicine (Baltimore); 2023 Dec; 102(50):e36177. PubMed ID: 38115276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology Combined with Molecular Docking and Experimental Verification Reveals the Bioactive Components and Potential Targets of Danlong Dingchuan Decoction against Asthma.
    Xue B; Zhao Q; Chen D; Wang X; Li L; Li J; Tian J
    Evid Based Complement Alternat Med; 2022; 2022():7895271. PubMed ID: 35186104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of
    Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
    Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
    [No Abstract]   [Full Text] [Related]  

  • 14. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
    Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
    World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of Chaenomelis Fructus in treatment of rheumatoid arthritis based on network pharmacology and experimental verification].
    Duan ZH; Jin C; Deng Y; Liu JL; Wang J; Li SG; Zhou Y
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4852-4863. PubMed ID: 37802827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
    Gao LD; Liu J; Huang YH; Wang BH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamic mechanism of Tibetan medicine Liurui Capsules on experimental autoimmune uveitis in rats based on network pharmacology and animal experiments].
    Bian M; Zhou Z; Zhu CS; Nie AZ; Li XP
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6687-6695. PubMed ID: 36604919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
    Lin Y; Shen C; Wang F; Fang Z; Shen G
    J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
    Wu Z; Ji X; Shan C; Song J; Zhao J
    Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.